A study on assessment of knowledge, attitude and practice of premenstrual syndrome among female in urban area


  • V. Sireesha Department of Pharmacy, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India
  • Faiqua Fatima Department of Pharmacy, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India
  • Shafeen Sultana Department of Pharmacy, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India
  • M. Shiva Sai Kumar Department of Pharmacy, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India
  • Sumaya . Department of Pharmacy, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India
  • Rama Rao Tadikonda Department of Pharmacy, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India




Gonadotropin-releasing hormone, Knowledge, Pre menstrual syndrome, Prevalence


Background: Premenstrual syndrome (PMS) is a significant clinical disorder affecting a substantial percentage of women. This study aims to investigate the existence, knowledge, and attitude of female students towards PMS.

Methods: A cross-sectional descriptive study was conducted, with 250 female participants between the ages of 18 to 30 years. The participants completed a self-reporting menstrual distress questionnaire (MDQ) and a standardized health questionnaire to assess the prevalence and severity of premenstrual symptoms and also to assess the knowledge, attitude, and practice of PMS for subjective perceptions of health, stress, lifestyle, and demographic variables. The questionnaire was set in four parts, one each to assess the knowledge, the attitude, and practices regarding PMS and one to assess the gap between self-perceived PMS and actual PMS. The data were analysed using descriptive statistics.

Results: The results revealed that 80% of the participants reported experiencing PMS, but only 48% met the criteria defined by the American College of Obstetricians and Gynecologists (ACOG). The most common symptoms reported were irritability, mood swings, headache, fatigue, and menstrual cramps. PMS had a significant impact on participants’ normal life, with 60.4% reporting disturbances in their routine. While 51.2% believed that PMS/menstrual leave should be an option at universities, only 39.2% supported the idea at the workplace.

Conclusions: Surprisingly, over 60% of participants did nothing to relieve their PMS symptoms. So, there is a significant impact of PMS in the lives of urban women and it is also a common problem all over the globe. The study underscores the need for increased awareness and education about PMS and its management, as well as the importance of promoting a stress-free environment to mitigate its impact on women’s quality of life.


Speroff L, Fritz MA. Menstrual disorder. In: Clinical Gynecologic Endocrinology and Infertility. 8th edn. Philadelphia, PA: Lippincott Williams and Wilkins; 2011:568-578.

Dennerstein L, Lehert P, Heinemann K. Global study of women's experiences of premenstrual symptoms and their efects on daily life. Menopause Int. 2011;17:88-95.

Budeiri DJ, Li Wan Po A, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynecol. 1994;101(8):689-95.

Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatr. 1990;147(12):1634-6.

Soares CN, Cohen LS, Otto MW, Harlow BL. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J Womens Health Gend Based Med. 2001;10 (9):873-8.

Dennerstein L, Lehert P, Heinemann K. Epidemiology of premenstrual symptoms and disorders. Menopause Int. 2012;18(2):48-51.

Choi D, Lee DY, Lehert P, Lee IS, Kim SH, Dennerstein L. The impact of premenstrual symptoms on activities of daily life in Korean women. J Psychosom Obstet Gynaecol. 2010;31(1):10-5.

Ginsburg KA, Dinsay R. Premenstrual syndrome. In: Ransom SB, ed. Practical Strategies in Obstetrics and. Gynecology. Philadelphia, Pa: WB Saunders; 2000:684-694.

Hamaideh SH, Al‐Ashram SA, Al‐Modallal H. Premenstrual syndrome and premenstrual dysphoric disorder among Jordanian women. J Psychiatr Ment Health Nurs. 2014;21:60-8.

Purdue-Smithe AC, Manson JE, Hankinson SE, Bertone-Johnson ER. A prospective study of caffeine and coffee intake and premenstrual syndrome. Am J Clin Nutr. 2016;104 (2):499-507.

Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28:1-23.

Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med. 1999;8:1043-52.

Pearlstein T, Joliat MJ, Brown EB, Miner CM. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am J Obstet Gynecol. 2003;188:887-95.

ACOG Practice Bulletin. Premenstrual syndrome. Clinical management guidelines for obstetrician- gynecologists. Number 15. J Obstet Gynecol. 2001;73:183-91.

Stöppler MC. Premenstrual Syndrome (PMS). Emedicine Health. 2022. Available at: https://www.emedicinehealth.com/premenstrual_syndrome_pms/article_em.htm. Accessed on 14 May 2023.

Silva CM, Gigante DP, Carret ML, Fassa AG. Population study of premenstrual syndrome. Rev Saud Pub. 2006;40:47-56.






Original Research Articles